Buckle Up For Brand Take Off: FDA's Checklist For Pilot Participants
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed pilot to expedite proprietary name reviews would require sponsors to submit more comprehensive safety data, shifting the burden of testing look-alike, sound-alike names for medication errors. CDER and CBER recommend applicants submit the following information: